Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Cell Biosciences Acquires Brightwell Technologies

May 12, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., May 12, 2011 /- Cell Biosciences, Inc. today announced that it has acquired Brightwell Technologies, Inc. of Ottawa, Ontario for approximately U.S. $9 million in cash. Brightwell Technologies is the market leader in Micro-Flow Imaging (MFI), an analytical technique...

Professor Cyrus Cooper awarded prestigious Heberden Medal

May 12, 2011 12:36 am | by International Osteoporosis Foundation | News | Comments

The British Society for Rheumatology recognizes the Chair of IOF's Committee of Scientific Advisors for his outstanding achievements in osteoporosis research

Inovio Pharmaceuticals' Market-Leading Intellectual Property Recognized by MDB Capital Award

May 12, 2011 12:35 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., May 12, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that MDB Capital Group has recognized Inovio with its CLARUS Award, given annually to...

Advertisement

Two Devices Treat Alzheimer's

May 11, 2011 8:34 pm | by Massachusetts Institute of Technology | News | Comments

Companies hope that brain stimulation will work where drugs have failed.

Dynatronics to Release Fiscal Third Quarter Results Monday, May 16, 2011; Conference Call Set for 1:00 p.m. ET(2)

May 11, 2011 5:36 pm | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, May 11, 2011 /- Dynatronics Corporation (Nasdaq: DYNT ) plans to release financial results for its quarter ended March 31, 2011 during the morning of Monday, May 16, 2011.   Dynatronics has scheduled a conference call for investors later that day at 1:00 p.m. ET to...

Doctors in Germany Among First to Use New Self-Expanding Clot Removal Device for Ischemic Stroke

May 11, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

RAYNHAM, Mass., May 11, 2011 /- Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE™ SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in...

How are you influencing patient management devices?

May 11, 2011 10:17 am | Articles | Comments

Rudye McGlothlin, Product Marketing Engineer at Texas Instruments, Chris Mertens, Vice President of Healthcare at HP PSG, and Alex Brisbourne, President and COO at KORE Telematics, respond to the question, “How are you influencing patient management devices?”

HCB Health Wins Manny Award for Best Medical Device Campaign

May 11, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, May 11, 2011 /- HCB Health, one of the top 25 independent healthcare communications agencies in the nation and the leading healthcare agency in the Southwest, won a Manny Award for best medical device campaign in the 22nd annual Manny Awards, a national competition honoring...

Advertisement

Fredericksburg Nephrology Associates, Inc., Successfully Attests to Meaningful Use Using Acumen EHR

May 11, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., May 11, 2011 /- Health IT Services Group (HITSG) announced that on Monday, April 18, 2011, Fredericksburg Nephrology Associates, Inc. (FNA) in Fredericksburg, Virginia, successfully attested to meaningful use using Acumen nEHR version 6.0. Fredericksburg Nephrology,...

Brain focused BeCaid joins incubator

May 11, 2011 8:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Yale University spinout BeCaid LLC, which is working on brain development programs that are tied to physical exercise, has become the latest member of Connecticut Innovations' CTech@Science Park incubator at Yale in New Haven, Conn.

Animas and LifeScan Strengthen Strategic Focus to Better Serve People Living with Diabetes

May 11, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

WEST CHESTER, Pa., May 11, 2011 /- Animas Corporation and LifeScan, Inc., both members of the Johnson & Johnson Family of Diabetes Companies, today announced plans to further build upon their existing collaborative efforts to co-develop and market innovative new products and tools for...

Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation

May 11, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., May 11, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced that a jury in the District Court for the District of Delaware found that Cordis Corporation owed Boston Scientific approximately $19.5 million for infringing its Jang patent, which covers...

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

May 11, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 11, 2011 /- Amira Pharmaceuticals, Inc. announced today that it will present preclinical data on AM152, an LPA1 receptor antagonist, during the Annual Meeting of the American Thoracic Society (ATS) in Denver, Colorado.  The poster, titled "The LPA1 Antagonist, AM152,...

Advertisement

Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix

May 11, 2011 7:39 am | by Bio-Medicine.Org | News | Comments

FORT WORTH, Texas, May 11, 2011 /- Healthpoint Biotherapeutics today announced the introduction of OASIS® Ultra Tri-Layer Matrix, a natural extracellular matrix (ECM) material derived from three layers of porcine small intestinal submucosa (SIS). The three-layer construct of ECM was...

Prexa releases details on $7M funding

May 11, 2011 7:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Prexa Pharmaceuticals today revealed that Shire Pharmaceuticals was among the investors in Prexa's $7 million Series B financing, which was first reported in a filing with the U.S. Securities and Exchange Commission in late April.

Draft Guidance for Industry and Food and Drug Administration Staff - Establishing the Performance Characteristics of In Vitro Diagnostic Devices for Chlamydia trachomatis and/...

May 11, 2011 6:32 am | by U.S. Food & Drug Administration | News | Comments

These devices are used to aid in the diagnosis of urogenital C. trachomatisand/or N. gonorrhoeae infection. They include devices that detect one specific organism, as well as devices that may detect both organisms with or without further differentiation.

Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate

May 11, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, May 11, 2011 /- Instacare Corp. (OTCQB: ISCR), the exclusive provider of the Shasta Genstrip, a revolutionary diagnostic product targeted at the $20 billion diabetes care marketplace, a leading provider of prescription diagnostics and home testing products for the chronically...

Quick Delivery on EMI Filters That Eliminate RF Interference

May 11, 2011 6:18 am | Lcr Electronics | Product Releases | Comments

LCR Electronics, a leading manufacturer of EMI filters, backplanes, rugged system enclosures and electronic control products, now offers two new series of EMI Filters for MRI...

China Pharma Holdings, Inc. Reports First Quarter 2011 Financial Results

May 11, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

HAIKOU CITY, China, May 11, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI ) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the quarter ended March 31, 2011. F irst...

ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor

May 11, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

EXTON, Pa., May 11, 2011 /- ViroPharma Incorporated (Nasdaq: VPHM ) and Halozyme Therapeutics (Nasdaq: HALO)announced today that Halozyme has granted ViroPharma an exclusive worldwide license to use Halozyme's proprietary Enhanze™ technology, a proprietary drug delivery platform...

Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor human)

May 11, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 11, 2011 /- Halozyme Therapeutics, Inc. (Nasdaq: HALO ) and ViroPharma Incorporated (Nasdaq: VPHM ), today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) in the development of a subcutaneous...

Medco Research Institute® and AssureRx Health Initiate Pilot Program to Evaluate Adoption and Clinical Impact of Pharmacogenetic Testing for Selection of Psychotropic Medicat...

May 11, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J. and CINCINNATI, May 11, 2011 /- Medco Research Institute LLC , a wholly owned subsidiary of Medco Health Solutions Inc. (NYSE: MHS ), and AssureRx Health Inc. today announced the initiation of the PREDICT PSYMEDS pilot [Pharmacogenetic-Directed Prescribing of...

Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger

May 11, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., May 11, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, and Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), announced today the completion of the final extension of the...

Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Approaches at the American Urological Association Meeting in Washington, D.C.

May 11, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., May 11, 2011 /- Varian Medical Systems (NYSE: VAR ) will showcase the company's full spectrum of prostate cancer treatment technologies at the upcoming American Urological Association (AUA) Meeting in Washington, D.C.  During the meeting, Varian will sponsor a...

2nd Asia-Pacific Osteoporosis & Bone Meeting -Submit your abstract by May 17th

May 11, 2011 5:33 am | by International Osteoporosis Foundation | News | Comments

Less than one week to abstract deadline - young Investigators eligible for awards

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading